Abstract Title
Efficacy, safety, immunogenicity, and cross-reactivity of intramuscular HIL-214 norovirus vaccine in healthy children 5 Months of age at initial vaccination
Presenter
Robert Hershberg, HilleVax
Co-Author(s)
Rodrigo DeAntonio1, Robert Hershberg2, Jan Vinjé3, Claudio Lanata4, Xavier Sáez-Llorens1, Dommie Arias1, Dora Estripeaut1, Sonia Mazara5, Luis M. Franchi4, Tirza De León1, Agustin Bueso6, Mario R. Castillo7, Lourdes A. Peña8, Sara E. Rivera9, Demian A. Herrera10, Pío López11, Hernando A. Mendez12, Dania Torres13, Patria Aracena14, Jeffrey Quinones-Gonzalez15, Kashif R. Ali16, Mark R. Zweigart17, Paul D. Brewer-Jensen17, Svetlana Rayner18, Grace Chen2, Christopher Aakre2, Aditya Kohli2, Michael E. Abram2, Ralph S. Baric17, Lisa C. Lindesmith17, and Astrid Borkowski18
1 Centro de Vacunación Internacional (CEVAXIN), Panama City, Panama, 2 HilleVax, Inc., Boston, MA, United States, 3 Centers for Disease Control and Prevention, Atlanta, GA, United States, 4 Instituto de Investigacion Nutricional (IIN), Lima, Peru, 5 Hospital Universitario Maternidad Nuestra Señora de la Altagracia, Santo Domingo, Dominican Republic, 6 Demedica S.de R.L., San Pedro Sula, Honduras, 7 Investigacion sin Limites S. de R.L., Tegucigalpa, Honduras, 8 Clinica Cruz Jiminian, SRL, Santo Domingo, Dominican Republic, 9 Inversiones en Investigación Médica S.A (INVERIME), Tegucigalpa, Honduras, 10 Hospital Pediatrico Dr. Hugo Mendoza, Santo Domingo, Dominican Republic, 11 Centro de estudios en Infectologia Pediátrica (CEIP), Cali, Columbia, 12 Policlínico Social del Norte, Bogotá, Columbia, 13 Registrum Group/Hospital General Regional Dr Marcelino Velez Santana, Santo Domingo, Dominican Republic, 14 Caimed Dominicana S.A.S, Santo Domingo, Dominican Republic, 15 Clinical Research Puerto Rico, Guayama, Puerto Rico, 16 DM Clinical Research, Houston, TX, United States, 17 Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 18 HilleVax, GmbH, Glattpark-Zurich, Switzerland
Abstract Category
Vaccines and immunity
Abstract
Background: Norovirus-associated acute gastroenteritis (AGE) is a major cause of morbidity and mortality in children